LadRx Corp

About LadRx Corp

LadRx Corporation is a biopharmaceutical company focused on oncology, developing targeted anti-cancer drug candidates using novel LADR technology that delivers potent chemotherapeutics directly to solid tumors via albumin binding. Its pipeline includes tumor-targeting conjugates and companion diagnostics, aiming to improve efficacy and reduce side effects. The company seeks licensing, partnerships, and regulatory approvals to commercialize its innovative therapies for cancer treatment.